Camptothecin
This graph shows the total number of publications written about "Camptothecin" by people in the URMC Research Network by year, and whether "Camptothecin" was a major or minor topic of these publication.
Below are the most recent publications written about "Camptothecin" by people in Profiles.
-
Mohile SG, Schleicher L, Petrylak DP. Treatment of metastatic urachal carcinoma in an elderly woman. Nat Clin Pract Oncol. 2008 Jan; 5(1):55-8.
-
Pandya KJ, Dahlberg S, Hidalgo M, Cohen RB, Lee MW, Schiller JH, Johnson DH. A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500). J Thorac Oncol. 2007 Nov; 2(11):1036-41.
-
Huang M, Gao H, Chen Y, Zhu H, Cai Y, Zhang X, Miao Z, Jiang H, Zhang J, Shen H, Lin L, Lu W, Ding J. Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin Cancer Res. 2007 Feb 15; 13(4):1298-307.
-
Liang H. Comparison of antitumor activities in tumor xenograft treatment. Contemp Clin Trials. 2007 Feb; 28(2):115-9.
-
Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64(2):382-91.
-
Liang H. Modeling antitumor activity in xenograft tumor treatment. Biom J. 2005 Jun; 47(3):358-68.
-
Salama JK, Haraf DJ, Stenson K, Milano MT, Witt ME, Vokes EE. Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer. Cancer J. 2005 Mar-Apr; 11(2):140-6.
-
Woo MH, Peterson JK, Billups C, Liang H, Bjornsti MA, Houghton PJ. Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models. Cancer Chemother Pharmacol. 2005 May; 55(5):411-9.
-
Liang H, Sha N. Modeling antitumor activity by using a non-linear mixed-effects model. Math Biosci. 2004 May; 189(1):61-73.
-
Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):7951-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
